First Trust Advisors’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,387
Closed -$966K 2523
2021
Q1
$966K Buy
2,387
+587
+33% +$238K ﹤0.01% 1997
2020
Q4
$1.2M Buy
+1,800
New +$1.2M ﹤0.01% 1820